Showing results (361-370 of 708) with videos related to

Sort By:
Pageof 71
Artery|January 1, 1980
Influence of proteoglycans (PG) and glycosaminoglycans (GAG) on ADP-, collagen- and thrombin-induced platelet aggregationK Klein, H Sinzinger, K Silberbauer, et al.
European Journal of Nuclear Medicine|March 1, 2014
Comparative (99m)Tc-MIBI, (99m)Tc-tetrofosmin and (99m)Tc-furifosmin uptake in human soft tissue sarcoma cell linesM Rodrigues, F Chehne, W Kalinowska, et al.
Wiener Klinische Wochenschrift|July 10, 1981
[Platelet sensitivity to prostacyclin (PGI2) in patients with juvenile-onset diabetes mellitus (author's transl)]K Klein, H Sinzinger, G Schernthaner, et al.
Wiener Klinische Wochenschrift|December 11, 1981
[Prostacyclin formation in human cancer tissue of the gastrointestinal tract (author's transl)]C Gisinger, H Sinzinger, A Ferlitsch, et al.
Cardiology|January 1, 1981
Plasma concentrations of plbatelet-specific proteins in coronary artery diseaseI Mühlhauser, G Schernthaner, K Silberbauer, et al.
Artery|January 1, 1980
Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseasesI Mühlhauser, G Schernthaner, K Silberbauer, et al.
Lancet (London, England)|December 15, 1984
Detection of aneurysms by gamma-camera imaging after injection of autologous labelled plateletsH Sinzinger, J O'Grady, P Fitscha, et al.
Progress in Clinical and Biological Research|January 1, 1987
Increased plasma-6-oxo-PGF1-alpha but normal PGI2 half-life in patients with maxillo-facial tumorsH Porteder, M Matejka, G Kment, et al.
Thrombosis Research|June 15, 1988
Comparable effect of prostaglandin E1 in decreasing in vivo platelet deposition on human lesion sites after intravenous and intraarterial applicationH Sinzinger, J O'Grady, P Fitscha, et al.
Applied Pathology|January 1, 1986
Platelet plasma membrane changes in human type IIa hypercholesterolemiaG Bianciardi, G Weber, P Toti, et al.
Pageof 71